Read about recent events, essential information and the latest community news.
There’s an assumption that still shows up in how scale is discussed across advanced therapies, even if it’s rarely stated outright. Once a program proves itself clinically, scale is expected to follow Read more...
Daniel J. Weiss, MD, PhD President, ISCT University of Vermont United States Greetings and thank you all again for the privilege and opportunity to serve as President for the next 2 years. Following Read more...
Developed by ISCT Business Development & Finance Committee The year 2025 marked a notable period of momentum for the cell and gene therapy (CGT) sector, characterised by significant deal making across Read more...
Fajar Dumadi, BSc International Society for Cell & Gene Therapy (ISCT) Canada Following the release of the latest edition of the ISCT CGT Global Regulatory Report —presenting a comprehensive year-end Read more...
Tuula Rintala Director, Quality of Care and Advocacy EBMT, European Society for Blood and Marrow Transplantation Spain CAR-T cell therapy has transformed the treatment landscape for patients with Read more...
Introduction In the rapidly evolving landscape of advanced therapies, few challenges are as complex — or as consequential — as scaling cell therapy manufacturing to meet growing clinical and commercial Read more...
Madhavi Lakkaraja, MD, MPH Fred Hutchinson Cancer Center, University of Washington School of Medicine United States From ISCT 2025 Roundtable Session: Cell Therapies to Manage GVHD - Learning From Read more...
Hannah Song, PhD Contributing Editor, ISCT Telegraft National Institutes of Health United States It is my great honor and privilege to write to you today as a newly-minted Telegraft Editorial Read more...
Rajdeep Das, MD, PhD, FIBMS Member, ISCT Lab Practices Committee University Hospitals Cleveland Medical Center United States Karen E. Martin, PhD Department of Biomedical Engineering Tufts University Read more...
Shyam Bhakta, MD, MBA Contributing Editor, ISCT Telegraft United States Dr. Mary Laughlin grew up in Buffalo, NY, where the Roswell Park Cancer Center and Institute is located and where she also completed Read more...